Bank of America’s Immunomedics Inc IMMU Stock Holding History

Bank of America’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,350,000	Closed	-$19.7M	–	7446
2018 Q1	$19.7M	Hold	1,350,000	–	–	﹤0.01%	1783
2017 Q4	$21.8M	Buy	+1,350,000	New	+$15.9M	﹤0.01%	1732
2014 Q4	–	Sell	-1,400	Closed	-$5K	–	8095
2014 Q3	$5K	Buy	+1,400	New	+$4.73K	﹤0.01%	7566
2014 Q2	–	Sell	-2,200	Closed	-$9K	–	8301
2014 Q1	$9K	Buy	2,200 +2,000	+1,000%	+$9.92K	﹤0.01%	7220
2013 Q4	$1K	Buy	+200	New	+$891	﹤0.01%	7761

Bank of America's IMMU Position: Q4 2020 in Review

Bank of America sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,076,061 shares — an estimated $91.5M sold.

Bank of America first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $91.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Bank of America reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Bank of America sold 1,076,061 Immunomedics Inc shares in Q4 2020, an estimated $91.5M.
Bank of America first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
Bank of America's Immunomedics Inc position peaked at $91.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.